Trifluoperazine

Trifluoperazine

SCHEMBL24866

CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

DRD2DRD3DRD4HTR2AHTR2C

The experimentally established mechanism targets of Trifluoperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 known ✓ P14416 3/20 1.00
HTR2A known ✓ P28223 3/20 1.00
HTR2C known ✓ P28335 3/20 1.00
DRD3 known ✓ P35462 3/20 1.00
DRD4 known ✓ P21917 2/20 0.82
FPR2 P25090 11/20 1.00
LMNA P02545 7/20 1.00
MAPT P10636 7/20 1.00
SMN1; SMN2 Q16637 6/20 1.00
CYP3A4 P08684 5/20 1.00
MAPK1 P28482 5/20 1.00
TP53 P04637 4/20 1.00
RAD52 P43351 3/20 1.00
CYP1A2 P05177 3/20 1.00
HTR1A P08908 3/20 1.00
ADRA2A P08913 3/20 1.00
ADORA3 P0DMS8 3/20 1.00
CYP2D6 P10635 3/20 1.00
CHRM1 P11229 3/20 1.00
ADRA2B P18089 3/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoperazine SCHEMBL29603012 1.00 FPR2 (1.00) FPR2LMNAMAPTSMN1; SMN2CYP3A4
Trifluoperazine SCHEMBL1897003 1.00 FPR2 (1.00) FPR2LMNAMAPTSMN1; SMN2CYP3A4
Trifluoperazine SCHEMBL29430171 0.99 LMNA (1.00) FPR2LMNAMAPTSMN1; SMN2CYP3A4
Trifluoperazine SCHEMBL41194 0.99 LMNA (1.00) FPR2LMNAMAPTSMN1; SMN2CYP3A4
Trifluoperazine SCHEMBL29579627 0.99 LMNA (1.00) FPR2LMNAMAPTSMN1; SMN2CYP3A4
Trifluoperazine SCHEMBL23039392 0.99 LMNA (1.00) FPR2LMNAMAPTSMN1; SMN2CYP3A4
Trifluoperazine SCHEMBL341516 0.99 LMNA (1.00) FPR2LMNAMAPTSMN1; SMN2CYP3A4
Trifluoperazine SCHEMBL466955 0.98 FPR2 (0.96) FPR2LMNAMAPTSMN1; SMN2CYP3A4
SCHEMBL21445272 0.98 FPR2 (1.00) FPR2LMNAMAPTSMN1; SMN2CYP3A4
Trifluoperazine SCHEMBL28329317 0.95 FPR2 (0.90) FPR2LMNAMAPTSMN1; SMN2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 21902 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3841097-B1 2,6-BIS(((1H-BENZO[D]IMIDAZOL-2-YL)THIO)METHYL)PYRIDINE AND N2,N6-DIBENZYLPYRIDINE-2,6-DICARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITORS FOR TREATING CANCER BIOMEDICAL RES FOUNDATION OF THE ACADEMY OF ATHENS BRFAA (GR) 2026-05-20 EP claimed
US-12624036-B2 Method of treating post-traumatic stress disorder INTRA-CELLULAR THERAPIES, INC. (US) 2026-05-12 US claimed
CN-122028919-A Compositions and methods for treating cancer by affecting cancer cell membrane receptors and exosomes derived therefrom 黄奇英 2026-05-12 CN claimed
US-12624037-B2 Method of treating agitation, aggressive behavior, and impulse control disorder INTRA-CELLULAR THERAPIES, INC. (US) 2026-05-12 US claimed
EP-4736841-A1 A MUCOADHESIVE LAYER FOR BUCCAL ADMINISTRATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT IQ medical GmbH (DE) 2026-05-06 EP claimed
US-20260098070-A1 SMAGP FUSION MOLECULES AND METHODS OF USE THEREOF DEM BIOPHARMA INC (US) 2026-04-09 US claimed
US-20260092932-A1 METHODS AND COMPOSITIONS FOR THE DETECTION, DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDER THE JOHNSON CENTER FOR CHILD HEALTH AND DEV (US) 2026-04-02 US claimed
EP-4699659-A2 CRYSTALLINE FORMS OF EVENAMIDE Newron Pharmaceuticals S.p.A. (IT) 2026-02-25 EP claimed
EP-4648734-B1 SUNSCREEN COMPOSITION WITH FUNCTIONALIZED ZEOLITE SPF BOOSTERS GETTERS SPA (IT) 2026-02-18 EP claimed
US-12550885-B2 Red blood cell storage solutions, solution additives, and methods for improving the storage of red blood cells UNIVERSITY OF CINCINNATI (US) 2026-02-17 US claimed
US-4407800-A TRYPANOCIDES UNIVERSITY OF VIRGINIA ALUMNI PATENTS FOUNDATION (US) 1983-10-04 US claimed
EP-0082203-A1 USE OF CALMODULIN BINDING DRUGS IN UTERUS TO PREVENT PREGNANCY THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 1983-06-29 EP claimed
US-4377577-A Use of psychoactive drugs in uterus to prevent pregnancy UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 1983-03-22 US claimed
WO-1983000086-A1 USE OF CALMODULIN BINDING DRUGS IN UTERUS TO PREVENT PREGNANCY UNIV GEORGIA RES FOUND (US) 1983-01-20 WO claimed
US-4369172-A Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose FOREST LABORATORIES INC. (US) 1983-01-18 US claimed
EP-0053108-A1 VAGINAL CONTRACEPTIVES COMPRISING PSYCHOACTIVE DRUGS THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 1982-06-09 EP claimed
WO-1981003421-A1 USE OF PSYCHOACTIVE DRUGS AS VAGINAL CONTRACEPTIVES UNIV GEORGIA (US) 1981-12-10 WO claimed
US-4287307-A MICROCELLULAR, PLASTICIZING, FOOTWEAR PLASTICS TECHNOLOGY ASSOCIATES, INC. (US) 1981-09-01 US claimed
US-4197288-A Neuroleptic radioreceptor assay method and kit BURROUGHS WELLCOME CO. (US) 1980-04-08 US claimed
US-4175119-A Composition and method to prevent accidental and intentional overdosage with psychoactive drugs PORTER GARRY L 1979-11-20 US claimed